{
    "Trade/Device Name(s)": [
        "D\u00b3 FastPoint L-DFA Parainfluenza Virus/Adenovirus Identification Kit",
        "D\u00b3 FastPoint Parainfluenza Virus/Adenovirus Identification Kit"
    ],
    "Submitter Information": "Diagnostic Hybrids, Inc.",
    "510(k) Number": "K093415",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061101",
        "K081928"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GQS",
        "GNY"
    ],
    "Summary Letter Date": "December 23, 2009",
    "Summary Letter Received Date": "November 2, 2009",
    "Submission Date": "October 30, 2009",
    "Regulation Number(s)": [
        "21CFR866.3400",
        "21CFR866.3020"
    ],
    "Regulation Name(s)": [
        "Parainfluenza Virus Serological Reagents",
        "Adenovirus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Adenovirus",
        "Parainfluenza virus type 1",
        "Parainfluenza virus type 2",
        "Parainfluenza virus type 3"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal aspirate",
        "Nasopharyngeal aspirate",
        "Nasal wash",
        "Nasopharyngeal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Fluorescence microscope"
    ],
    "Method(s)/Technology(ies)": [
        "Direct fluorescent antibody (DFA)",
        "Immunofluorescence",
        "Monoclonal antibody labeling"
    ],
    "Methodologies": [
        "Antigen detection",
        "Immunofluorescence staining"
    ],
    "Submission Type(s)": [
        "Kit",
        "Reagent",
        "Antibody",
        "Control",
        "Slide"
    ],
    "Document Summary": "FDA 510(k) summary for D\u00b3 FastPoint L-DFA Parainfluenza Virus/Adenovirus Identification Kit for qualitative detection of adenovirus and parainfluenza virus types 1-3 antigens by immunofluorescence in respiratory specimens.",
    "Indications for Use Summary": "Intended for qualitative identification of adenovirus and screening for parainfluenza virus types 1, 2, and 3 in nasal and nasopharyngeal swabs and aspirates/washes from patients with signs and symptoms of respiratory infection, using direct immunofluorescence with monoclonal antibodies.",
    "fda_folder": "Microbiology"
}